Cargando…

Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015

BACKGROUND: The last evaluation to assess outcomes for patients receiving antiretroviral therapy (ART) through the Zimbabwe public sector was conducted in 2011, covering the 2007–2010 cohorts. The reported retention at 6, 12, 24 and 36 months were 90.7%, 78.1%, 68.8% and 64.4%, respectively. We repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Makurumidze, Richard, Mutasa-Apollo, Tsitsi, Decroo, Tom, Choto, Regis C., Takarinda, Kudakwashe C., Dzangare, Janet, Lynen, Lutgarde, Van Damme, Wim, Hakim, James, Magure, Tapuwa, Mugurungi, Owen, Rusakaniko, Simbarashe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946589/
https://www.ncbi.nlm.nih.gov/pubmed/31910445
http://dx.doi.org/10.1371/journal.pone.0222309
_version_ 1783485394603474944
author Makurumidze, Richard
Mutasa-Apollo, Tsitsi
Decroo, Tom
Choto, Regis C.
Takarinda, Kudakwashe C.
Dzangare, Janet
Lynen, Lutgarde
Van Damme, Wim
Hakim, James
Magure, Tapuwa
Mugurungi, Owen
Rusakaniko, Simbarashe
author_facet Makurumidze, Richard
Mutasa-Apollo, Tsitsi
Decroo, Tom
Choto, Regis C.
Takarinda, Kudakwashe C.
Dzangare, Janet
Lynen, Lutgarde
Van Damme, Wim
Hakim, James
Magure, Tapuwa
Mugurungi, Owen
Rusakaniko, Simbarashe
author_sort Makurumidze, Richard
collection PubMed
description BACKGROUND: The last evaluation to assess outcomes for patients receiving antiretroviral therapy (ART) through the Zimbabwe public sector was conducted in 2011, covering the 2007–2010 cohorts. The reported retention at 6, 12, 24 and 36 months were 90.7%, 78.1%, 68.8% and 64.4%, respectively. We report findings of a follow-up evaluation for the 2012–2015 cohorts to assess the implementation and impact of recommendations from this prior evaluation. METHODS: A nationwide retrospective study was conducted in 2016. Multi-stage proportional sampling was used to select health facilities and study participants records. The data extracted from patient manual records included demographic, baseline clinical characteristics and patient outcomes (active on treatment, died, transferred out, stopped ART and lost to follow-up (LTFU)) at 6, 12, 24 and 36 months. The data were analysed using Stata/IC 14.2. Retention was estimated using survival analysis. The predictors associated with attrition were determined using a multivariate Cox regression model. RESULTS: A total of 3,810 participants were recruited in the study. The median age in years was 35 (IQR: 28–42). Overall, retention increased to 92.4% (p-value = 0.060), 86.5% (p-value<0.001), 79.2% (p-value<0.001) and 74.4% (p-value<0.001) at 6, 12, 24 and 36 months respectively. LTFU accounted for 98% of attrition. Being an adolescent or a young adult (15–24 years) (vs adult;1.41; 95% CI:1.14–1.74), children (<15years) (vs adults; aHR 0.64; 95% CI:0.46–0.91), receiving care at primary health care facility (vs central and provincial facility; aHR 1.23; 95% CI:1.01–1.49), having initiated ART between 2014–2015 (vs 2012–2013; aHR1.45; 95%CI:1.24–1.69), having WHO Stage IV (vs Stage I-III; aHR2.06; 95%CI:1.51–2.81) and impaired functional status (vs normal status; aHR1.25; 95%CI:1.04–1.49) predicted attrition. CONCLUSION: The overall retention was higher in comparison to the previous 2007–2010 evaluation. Further studies to understand why attrition was found to be higher at primary health care facilities are warranted. Implementation of strategies for managing patients with advanced HIV disease, differentiated care for adolescents and young adults and tracking of LTFU clients should be prioritised to further improve retention.
format Online
Article
Text
id pubmed-6946589
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69465892020-01-17 Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015 Makurumidze, Richard Mutasa-Apollo, Tsitsi Decroo, Tom Choto, Regis C. Takarinda, Kudakwashe C. Dzangare, Janet Lynen, Lutgarde Van Damme, Wim Hakim, James Magure, Tapuwa Mugurungi, Owen Rusakaniko, Simbarashe PLoS One Research Article BACKGROUND: The last evaluation to assess outcomes for patients receiving antiretroviral therapy (ART) through the Zimbabwe public sector was conducted in 2011, covering the 2007–2010 cohorts. The reported retention at 6, 12, 24 and 36 months were 90.7%, 78.1%, 68.8% and 64.4%, respectively. We report findings of a follow-up evaluation for the 2012–2015 cohorts to assess the implementation and impact of recommendations from this prior evaluation. METHODS: A nationwide retrospective study was conducted in 2016. Multi-stage proportional sampling was used to select health facilities and study participants records. The data extracted from patient manual records included demographic, baseline clinical characteristics and patient outcomes (active on treatment, died, transferred out, stopped ART and lost to follow-up (LTFU)) at 6, 12, 24 and 36 months. The data were analysed using Stata/IC 14.2. Retention was estimated using survival analysis. The predictors associated with attrition were determined using a multivariate Cox regression model. RESULTS: A total of 3,810 participants were recruited in the study. The median age in years was 35 (IQR: 28–42). Overall, retention increased to 92.4% (p-value = 0.060), 86.5% (p-value<0.001), 79.2% (p-value<0.001) and 74.4% (p-value<0.001) at 6, 12, 24 and 36 months respectively. LTFU accounted for 98% of attrition. Being an adolescent or a young adult (15–24 years) (vs adult;1.41; 95% CI:1.14–1.74), children (<15years) (vs adults; aHR 0.64; 95% CI:0.46–0.91), receiving care at primary health care facility (vs central and provincial facility; aHR 1.23; 95% CI:1.01–1.49), having initiated ART between 2014–2015 (vs 2012–2013; aHR1.45; 95%CI:1.24–1.69), having WHO Stage IV (vs Stage I-III; aHR2.06; 95%CI:1.51–2.81) and impaired functional status (vs normal status; aHR1.25; 95%CI:1.04–1.49) predicted attrition. CONCLUSION: The overall retention was higher in comparison to the previous 2007–2010 evaluation. Further studies to understand why attrition was found to be higher at primary health care facilities are warranted. Implementation of strategies for managing patients with advanced HIV disease, differentiated care for adolescents and young adults and tracking of LTFU clients should be prioritised to further improve retention. Public Library of Science 2020-01-07 /pmc/articles/PMC6946589/ /pubmed/31910445 http://dx.doi.org/10.1371/journal.pone.0222309 Text en © 2020 Makurumidze et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Makurumidze, Richard
Mutasa-Apollo, Tsitsi
Decroo, Tom
Choto, Regis C.
Takarinda, Kudakwashe C.
Dzangare, Janet
Lynen, Lutgarde
Van Damme, Wim
Hakim, James
Magure, Tapuwa
Mugurungi, Owen
Rusakaniko, Simbarashe
Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015
title Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015
title_full Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015
title_fullStr Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015
title_full_unstemmed Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015
title_short Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015
title_sort retention and predictors of attrition among patients who started antiretroviral therapy in zimbabwe’s national antiretroviral therapy programme between 2012 and 2015
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946589/
https://www.ncbi.nlm.nih.gov/pubmed/31910445
http://dx.doi.org/10.1371/journal.pone.0222309
work_keys_str_mv AT makurumidzerichard retentionandpredictorsofattritionamongpatientswhostartedantiretroviraltherapyinzimbabwesnationalantiretroviraltherapyprogrammebetween2012and2015
AT mutasaapollotsitsi retentionandpredictorsofattritionamongpatientswhostartedantiretroviraltherapyinzimbabwesnationalantiretroviraltherapyprogrammebetween2012and2015
AT decrootom retentionandpredictorsofattritionamongpatientswhostartedantiretroviraltherapyinzimbabwesnationalantiretroviraltherapyprogrammebetween2012and2015
AT chotoregisc retentionandpredictorsofattritionamongpatientswhostartedantiretroviraltherapyinzimbabwesnationalantiretroviraltherapyprogrammebetween2012and2015
AT takarindakudakwashec retentionandpredictorsofattritionamongpatientswhostartedantiretroviraltherapyinzimbabwesnationalantiretroviraltherapyprogrammebetween2012and2015
AT dzangarejanet retentionandpredictorsofattritionamongpatientswhostartedantiretroviraltherapyinzimbabwesnationalantiretroviraltherapyprogrammebetween2012and2015
AT lynenlutgarde retentionandpredictorsofattritionamongpatientswhostartedantiretroviraltherapyinzimbabwesnationalantiretroviraltherapyprogrammebetween2012and2015
AT vandammewim retentionandpredictorsofattritionamongpatientswhostartedantiretroviraltherapyinzimbabwesnationalantiretroviraltherapyprogrammebetween2012and2015
AT hakimjames retentionandpredictorsofattritionamongpatientswhostartedantiretroviraltherapyinzimbabwesnationalantiretroviraltherapyprogrammebetween2012and2015
AT maguretapuwa retentionandpredictorsofattritionamongpatientswhostartedantiretroviraltherapyinzimbabwesnationalantiretroviraltherapyprogrammebetween2012and2015
AT mugurungiowen retentionandpredictorsofattritionamongpatientswhostartedantiretroviraltherapyinzimbabwesnationalantiretroviraltherapyprogrammebetween2012and2015
AT rusakanikosimbarashe retentionandpredictorsofattritionamongpatientswhostartedantiretroviraltherapyinzimbabwesnationalantiretroviraltherapyprogrammebetween2012and2015